Showing results (1251-1260 of 3,351) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|May 4, 2015
The Economic and Humanistic Burden of Severe SepsisBogdan Tiru, Ernest K DiNino, Abigail Orenstein, et al.
Pharmacoeconomics|June 6, 2015
Ipilimumab for Previously Untreated Unresectable Malignant Melanoma: A Critique of the EvidenceChristina Giannopoulou, Eleftherios Sideris, Ros Wade, et al.
Pharmacoeconomics|October 25, 2019
Economic Burden of Anxiety Disorders: A Systematic Review and Meta-AnalysisAlexander Konnopka, Hannah König
Pharmacoeconomics|May 9, 2020
Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United StatesSang Kyu Cho, Beenish S Manzoor, Kavita R Sail, et al.
Pharmacoeconomics|May 5, 2020
A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost TypologyLucy Cunnama, Gabriela B Gomez, Mariana Siapka, et al.
Pharmacoeconomics|May 12, 2020
Health State Utility Values in Juvenile Idiopathic Arthritis: What is the Evidence?Luiza Raquel Grazziotin, Gillian Currie, Michelle M A Kip, et al.
Pharmacoeconomics|June 18, 2015
Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in GermanyKatharina Schremser, Wolf H Rogowski, Sigrid Adler-Reichel, et al.
Pharmacoeconomics|June 22, 2015
Big Data and Health Economics: Strengths, Weaknesses, Opportunities and ThreatsBrendan Collins
Pharmacoeconomics|June 22, 2015
Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost EffectivenessMikael Svensson, Fredrik O L Nilsson, Karl Arnberg
Pharmacoeconomics|April 29, 2020
Adherence to Discounting Guidelines: Evidence from Over 2000 Published Cost-Effectiveness AnalysesMichelle Q T Kwok, Mistura A Kareem, Michael J Cash, et al.
Pageof 336